|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of CytomX Therapeutics (NASDAQ: CTMX) through any online brokerage.
The latest price target for CytomX Therapeutics (NASDAQ: CTMX) was reported by Barclays on May 28, 2021. The analyst firm set a price target for 7.00 expecting CTMX to fall to within 12 months (a possible -3.31% downside). 4 analyst firms have reported ratings in the last year.
The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $7.24 last updated Today at 8:00:03 PM.
There are no upcoming dividends for CytomX Therapeutics.
There is no upcoming split for CytomX Therapeutics.
CytomX Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.